NIT
LXRX icon

NumerixS Investment Technologies’s Lexicon Pharmaceuticals LXRX Stock Holding History

NumerixS Investment Technologies’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,000
Closed -$123K – 1270
2017
Q3 		$123K Sell
10,000
-6,100
-38% -$90.1K 0.03% 676
2017
Q2 		$265K Buy
+16,100
New +$249K 0.04% 542
2017
Q1 		– Sell
-14,202
Closed -$196K – 1273
2016
Q4 		$196K Sell
14,202
-22,800
-62% -$366K 0.02% 675
2016
Q3 		$669K Sell
37,002
-7,371
-17% -$119K 0.09% 291
2016
Q2 		$637K Sell
44,373
-11,700
-21% -$159K 0.09% 325
2016
Q1 		$670K Buy
+56,073
New +$588K 0.08% 373

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CLM
ClearBridge LLC (Maryland) Baltimore, Maryland $329M AUM 9.73% 1-Year Est. Return